EZH2 and hepatocellular carcinoma: Elevated EZH2 expression is associated with poor prognosis in various cancers, including HCC, suggesting its potential as a prognostic biomarker10, the interaction between EZH2 expression and circadian rhythm-related genes has been emphasized, as disturbances in circadian rhythms can influence tumor development and patient outcomes11.